ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

Clinical trial NCT05082259 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05082259
Sponsor: Institute of Cancer Research, United Kingdom
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Cervical Cancer Triple Negative Breast Cancer

Start date: 2022-03-02
Primary completion: 2026-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.